Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
3.
Antioxidants (Basel) ; 9(9)2020 Sep 19.
Article in English | MEDLINE | ID: mdl-32961723

ABSTRACT

Acute pancreatitis is an inflammatory process of the pancreatic tissue that often leads to distant organ dysfunction. Although liver injury is uncommon in acute pancreatitis, obesity is a risk factor for the development of hepatic complications. The aim of this work was to evaluate the role of PGC-1α in inflammatory response regulation in the liver and its contribution to the detrimental effect of obesity on the liver during acute pancreatitis. For this purpose, we induced acute pancreatitis by cerulein in not only wild-type (WT) and PGC-1α knockout (KO) mice, but also in lean and obese mice. PGC-1α levels were up-regulated in the mice livers with pancreatitis. The increased PGC-1α levels were bound to p65 to restrain its transcriptional activity toward Nos2. Lack of PGC-1α favored the assembly of the p65/phospho-STAT3 complex, which promoted Nos2 expression during acute pancreatitis. The increased transcript Nos2 levels and the pro-oxidant liver status caused by the down-regulated expression of the PGC-1α-dependent antioxidant genes enhanced nitrosative stress and decreased energy charge in the livers of the PGC-1α KO mice with pancreatitis. It is noteworthy that the PGC-1α levels lowered in the obese mice livers, which increased the Nos2 mRNA expression and protein nitration levels and decreased energy charge during pancreatitis. In conclusion, obesity impairs PGC-1α up-regulation in the liver to cause nitrosative stress during acute pancreatitis.

4.
J Wrist Surg ; 9(4): 328-337, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32760612

ABSTRACT

Objective To describe a technique for treating acute injuries of the scapholunate ligament (SLL) by performing an arthroscopic reinsertion of the SLL and dorsal capsulodesis and to present the results obtained. Methods The study deals with an analytical, prospective clinical study that included 19 consecutive patients with acute injury of the SLL. The range of joint motion, grip strength, pain according to the visual analog scale, functional outcomes according to the Mayo Wrist Score (MWS), and the QuickDASH Score were studied preoperatively and 6 and 12 months postoperatively. The complications and necessary reinterventions were recorded. Results Nineteen patients with acute injury of the SLL were studied; mean age was 44 ± 2 years, 74% males, 58% complete rupture, and 42% partial rupture, treated with the above-mentioned technique. Thirty-seven percent also had a distal radius fracture and there was one case of perilunate dislocation. Improvement in pain, grip strength, joint balance, and functionality was observed 6 and 12 months postoperatively, with 79% of the cases with good or excellent results Conclusion The arthroscopic reinsertion and dorsal capsular reinforcement of the SLL, allow a reliable and stable primary repair of the dorsal aspect of the ligament in acute or subacute SL injuries where there is tissue that can potentially be repaired, thus achieving an anatomical repair similar to that obtained with open surgery, but without the complications and stiffness secondary to aggressive interventions on the soft tissues that are inherent to the open dorsal approach.

5.
Eur J Pharmacol ; 853: 33-40, 2019 Jun 15.
Article in English | MEDLINE | ID: mdl-30876977

ABSTRACT

Hydrogen sulfide (H2S) is a potential endothelium-derived hyperpolarizing factor (EDHF) and adventitium- or adipocyte-derived relaxing factor (ADRF) which vasorelaxant action is mediated by potassium channels. H2S could also play an important role in the pathophysiology of diabetic cardiovascular complications. The present study has investigated the influence of alloxan-induced diabetes on the role of potassium channels mediating the relaxant response of the rabbit carotid artery to NaHS, a donor of H2S. NaHS (10-8-3 × 10-5 M) relaxed phenylephrine-precontracted carotid arteries, with higher potency in diabetic than in control rabbits. The selective blockers of potassium channels charybdotoxin, 4-amynopiridine and glibenclamide significantly inhibited the relaxant action of NaHS in diabetic rabbits, but not in control rabbits. When compared to control rabbits, carotid arteries from diabetic rabbits showed significantly reduced expression of big conductance Ca+2-activated potassium channels (BKCa), significantly enhanced expression of intermediate conductance Ca+2-activated potassium channels (IKCa) and not significant different expression of voltage-sensitive potassium channels (KV) and ATP-sensitive potassium channels (KATP). These results suggest that an enhanced role of IKCa, KV and KATP potassium channels could be involved in the increased sensitivity of the rabbit carotid artery to H2S in diabetes.


Subject(s)
Carotid Arteries/drug effects , Carotid Arteries/physiopathology , Diabetes Mellitus, Experimental/metabolism , Hydrogen Sulfide/pharmacology , Potassium Channels/metabolism , Vasodilation/drug effects , Animals , Carotid Arteries/metabolism , Diabetes Mellitus, Experimental/physiopathology , Dose-Response Relationship, Drug , Male , Rabbits
6.
Mol Cell Endocrinol ; 472: 1-9, 2018 09 05.
Article in English | MEDLINE | ID: mdl-29842904

ABSTRACT

Along with its role in regulating blood pressure and fluid homeostasis, the natriuretic peptide system could be also part of an endogenous protective mechanism against brain damage. We aimed to assess the possibility that exogenous atrial natriuretic peptide (ANP) could protect against acute ischemic stroke, as well as the molecular mechanisms involved. Three groups of rats subjected to transient middle cerebral artery occlusion (tMCAO, intraluminal filament technique, 60 min) received intracerebroventricular vehicle, low-dose ANP (0.5 nmol) or high-dose ANP (2.5 nmol), at 30 min reperfusion. Neurofunctional condition, and brain infarct and edema volumes were measured at 24 h after tMCAO. Apoptotic cell death and expression of natriuretic peptide receptors (NPR-A and NPR-C), K+ channels (KATP, KV and BKCa), and PI3K/Akt and MAPK/ERK1/2 signaling pathways were analyzed. Significant improvement in neurofunctional status, associated to reduction in infarct and edema volumes, was shown in the high-dose ANP group. As to the molecular mechanisms analyzed, high-dose ANP: 1) reduced caspase-3-mediated apoptosis; 2) did not modify the expression of NPR-A and NPR-C, which had been downregulated by the ischemic insult; 3) induced a significant reversion of ischemia-downregulated KATP channel expression; and 4) induced a significant reversion of ischemia-upregulated pERK2/ERK2 expression ratio. In conclusion, ANP exerts a significant protective role in terms of both improvement of neurofunctional status and reduction in infarct volume. Modulation of ANP on some molecular mechanisms involved in ischemia-induced apoptotic cell death (KATP channels and MAPK/ERK1/2 signaling pathway) could account, at least in part, for its beneficial effect. Therefore, ANP should be considered as a potential adjunctive neuroprotective agent improving stroke outcome after successful reperfusion interventions.


Subject(s)
Atrial Natriuretic Factor/therapeutic use , Brain Ischemia/drug therapy , Neuroprotective Agents/therapeutic use , Stroke/drug therapy , Animals , Apoptosis/drug effects , Atrial Natriuretic Factor/pharmacology , Brain/drug effects , Brain/pathology , Brain Ischemia/complications , Caspase 3/metabolism , DNA Cleavage/drug effects , Down-Regulation , Infarction, Middle Cerebral Artery/complications , Infarction, Middle Cerebral Artery/pathology , Injections, Intraventricular , MAP Kinase Signaling System/drug effects , Male , Neuroprotective Agents/pharmacology , Phosphatidylinositol 3-Kinases/metabolism , Potassium Channels/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Rats, Wistar , Receptors, Atrial Natriuretic Factor/metabolism , Reperfusion Injury/complications , Reperfusion Injury/pathology , Stroke/complications
7.
Naunyn Schmiedebergs Arch Pharmacol ; 391(5): 501-511, 2018 05.
Article in English | MEDLINE | ID: mdl-29464270

ABSTRACT

Diabetic nephropathy is associated with increased risk of cardiovascular disease. B-type natriuretic peptide (BNP) plays an important role in cardiovascular pathophysiology and therapeutics. The aim of the present study was to investigate the influence of experimental diabetes on the mechanisms that regulate the relaxant response of the rabbit renal artery to BNP. Arterial relaxations to BNP were enhanced in diabetic rabbits. Indomethacin enhanced BNP-induced relaxation in control rabbits but showed no effect in diabetic rabbits. BNP-induced release of thromboxane A2 or prostacyclin was not different in both groups of animals. Iberiotoxin had no effect on relaxations to BNP in both groups of animals. Charybdotoxin displaced to the right the concentration-response curve to BNP in both group of animals, and inhibited BNP-induced relaxation only in diabetic rabbits. Glibenclamide did not modify the BNP-induced relaxations in control rabbits, but inhibited it in diabetic rabbits. These results suggest that diabetes induces hypereactivity of the rabbit renal artery to BNP by mechanisms that at least include (1) a reduced vasoconstrictor influence of arachidonic acid metabolites via cyclooxygenase 2, which is not related with changes in thromboxane A2 and prostacyclin release from the arterial wall and (2) a selectively increased modulatory activity of KATP and endothelial IKCa channels.


Subject(s)
Diabetes Mellitus, Experimental/physiopathology , Natriuretic Peptide, Brain/physiology , Potassium Channels/physiology , Prostaglandins/physiology , Renal Artery/physiology , Animals , Male , Rabbits , Vasodilation
8.
Eur J Pharmacol ; 815: 64-72, 2017 Nov 15.
Article in English | MEDLINE | ID: mdl-29024691

ABSTRACT

Atrial natriuretic peptide (ANP) is a vasodilator with significant regional differences and controversial effects in the cerebral circulation, a vascular bed particularly prone to diabetes-induced complications. The present study has investigated how alloxan-induced diabetes modifies the mechanisms involved in the response of the rabbit basilar artery to ANP. ANP (10-12-10-7M) relaxed precontracted basilar arteries, with higher potency in diabetic than in control rabbits. In arteries from both groups of animals, endothelium removal reduced ANP-induced relaxations. Inhibition of NO-synthesis attenuated ANP-induced relaxation but this attenuation was lower in diabetic than in control rabbits. In control rabbits, indomethacin displaced to the left the concentration-response curve to ANP, without significantly modifying the Emax value. In diabetic rabbits, indomethacin significantly enhanced arterial relaxations to ANP. In KCl-depolarised arteries, relaxation to ANP was almost abolished both in control and in diabetic rabbits. Iberiotoxin inhibited relaxations to ANP in both groups of rabbits. Glibenclamide and 4-aminopyridine inhibited the ANP-induced relaxations more in diabetic than in control rabbits. Basilar arteries from diabetic rabbits showed decreased natriuretic peptide receptor C expression and no changes in natriuretic peptide receptor A, large conductance calcium-activated K+ channels (BKCa), ATP-sensitive K+ channels (KATP) and voltage-sensitive K+ channels (KV) expression. These results suggest that diabetes enhances the sensitivity of the rabbit basilar artery to ANP by mechanisms that at least include reduced expression of natriuretic peptide receptor C, and enhanced activity of KATP and KV channels. Furthermore, diabetes reduces endothelial NO and prostacyclin which mediate arterial relaxation to ANP.


Subject(s)
Atrial Natriuretic Factor/pharmacology , Basilar Artery/drug effects , Basilar Artery/metabolism , Diabetes Mellitus, Experimental/metabolism , Animals , Dose-Response Relationship, Drug , Male , Nitric Oxide/metabolism , Prostaglandins/metabolism , Rabbits , Receptors, Atrial Natriuretic Factor/metabolism
9.
J Steroid Biochem Mol Biol ; 171: 296-304, 2017 07.
Article in English | MEDLINE | ID: mdl-28479229

ABSTRACT

As the knowledge on the estrogenic system in the brain grows, the possibilities to modulate it in order to afford further neuroprotection in brain damaging disorders so do it. We have previously demonstrated the ability of the selective estrogen receptor modulator, bazedoxifene (BZA), to reduce experimental ischemic brain damage. The present study has been designed to gain insight into the molecular mechanisms involved in such a neuroprotective action by investigating: 1) stroke-induced apoptotic cell death; 2) expression of estrogen receptors (ER) ERα, ERß and the G-protein coupled estrogen receptor (GPER); and 3) modulation of MAPK/ERK1/2 and PI3K/Akt signaling pathways. For comparison, a parallel study was done with 17ß-estradiol (E2)-treated animals. Male Wistar rats subject to transient right middle cerebral artery occlusion (tMCAO, intraluminal thread technique, 60min), were distributed in vehicle-, BZA- (20.7±2.1ng/mL in plasma) and E2- (45.6±7.8pg/mL in plasma) treated groups. At 24h from the onset of tMCAO, RT-PCR, Western blot and histochemical analysis were performed on brain tissue samples. Ischemia-reperfusion per se increased apoptosis as assessed by both caspase-3 activity and TUNEL-positive cell counts, which were reversed by both BZA and E2. ERα and ERß expression, but not that of GPER, was reduced by the ischemic insult. BZA and E2 had different effects: while BZA increased both ERα and ERß expression, E2 increased ERα expression but did not change that of ERß. Both MAPK/ERK1/2 and PI3K/Akt pathways were stimulated under ischemic conditions. While BZA strongly reduced the increased p-ERK1/2 levels, E2 did not. Neither BZA nor E2 modified ischemia-induced increase in p-Akt levels. These results show that modulation of ERα and ERß expression, as well as of the ERK1/2 signaling pathway accounts, at least in part, for the inhibitory effect of BZA on the stroke-induced apoptotic cell death. This lends mechanistic support to the consideration of BZA as a potential neuroprotective drug in acute ischemic stroke treatment.


Subject(s)
Brain Ischemia/drug therapy , Indoles/therapeutic use , Neurons/drug effects , Neuroprotective Agents/therapeutic use , Reperfusion Injury/prevention & control , Selective Estrogen Receptor Modulators/therapeutic use , Stroke/drug therapy , Animals , Apoptosis/drug effects , Brain Ischemia/metabolism , Brain Ischemia/pathology , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Estradiol/therapeutic use , Estrogen Receptor alpha/agonists , Estrogen Receptor alpha/genetics , Estrogen Receptor alpha/metabolism , Estrogen Receptor beta/agonists , Estrogen Receptor beta/genetics , Estrogen Receptor beta/metabolism , Estrogens/therapeutic use , MAP Kinase Signaling System/drug effects , Male , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Neurons/pathology , Phosphatidylinositol Phosphates/agonists , Phosphatidylinositol Phosphates/metabolism , Rats, Wistar , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Second Messenger Systems/drug effects , Stroke/metabolism , Stroke/pathology
10.
Crit Rev Food Sci Nutr ; 57(1): 197-211, 2017 Jan 02.
Article in English | MEDLINE | ID: mdl-26066523

ABSTRACT

Assessment of sustainability will become more relevant for the food industry in the years to come. Analysis based on exergy, including the use of exergetic indicators and Grassmann diagrams, is a useful tool for the quantitative and qualitative assessment of the efficiency of industrial food chains. In this paper, we review the methodology of exergy analysis and the exergetic indicators that are most appropriate for use in the food industry. The challenges of applying exergy analysis in industrial food chains and the specific features of food processes are also discussed.


Subject(s)
Efficiency, Organizational , Food Industry/methods , Food Quality , Food Supply/economics , Global Health , Models, Economic , Program Evaluation , Animals , Efficiency, Organizational/economics , Food Industry/economics , Food Industry/trends , Food, Preserved/analysis , Food, Preserved/economics , Food-Processing Industry/economics , Food-Processing Industry/methods , Food-Processing Industry/trends , Global Health/economics , Humans , Industrial Waste/economics , Industrial Waste/prevention & control , Nutritive Value , Program Evaluation/economics , Renewable Energy , Thermodynamics
11.
Neurosci Lett ; 575: 53-7, 2014 Jul 11.
Article in English | MEDLINE | ID: mdl-24861515

ABSTRACT

While the estrogen treatment of stroke is under debate, selective estrogen receptor modulators (SERMs) arise as a promising alternative. We hypothesize that bazedoxifene (acetate, BZA), a third generation SERM approved for the treatment of postmenopausal osteoporosis, reduces ischemic brain damage in a rat model of transient focal cerebral ischemia. For comparative purposes, the neuroprotective effect of 17ß-estradiol (E2) has also been assessed. Male Wistar rats underwent 60min middle cerebral artery occlusion (intraluminal thread technique), and grouped according to treatment: vehicle-, E2- and BZA-treated rats. Optimal plasma concentrations of E2 (45.6±7.8pg/ml) and BZA (20.7±2.1ng/ml) were achieved 4h after onset of ischemia, and maintained until the end of the procedure (24h). Neurofunctional score and volume of the damaged brain regions were the main end points. At 24h after ischemia-reperfusion, neurofunctional examination of the animals did not show significant differences among the three experimental groups. By contrast, both E2- and BZA-treated groups showed significantly lower total infarct volumes, BZA acting mainly in the cortical region and E2 acting mainly at the subcortical level. Our results demonstrate that: (1) E2 at physiological plasma levels in female rats is neuroprotective in male rats when given at the acute stage of the ischemic challenge and (2) BZA at clinically relevant plasma levels mimics the neuroprotective action of E2 and could be, therefore, a candidate in stroke treatment.


Subject(s)
Indoles/therapeutic use , Ischemic Attack, Transient/drug therapy , Neuroprotective Agents/therapeutic use , Selective Estrogen Receptor Modulators/therapeutic use , Animals , Brain/blood supply , Brain/drug effects , Brain/pathology , Brain Infarction/drug therapy , Brain Infarction/pathology , Estradiol/therapeutic use , Hemodynamics , Ischemic Attack, Transient/pathology , Ischemic Attack, Transient/physiopathology , Male , Rats, Wistar
12.
J Pediatr Orthop B ; 23(1): 93-9, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24201071

ABSTRACT

The choice of orthopedic or surgical treatment for Gartland type II supracondylar humeral fractures remains controversial. The aim of this study was to retrospectively compare the outcomes in orthopedic and surgical treatment in type II supracondylar humeral fractures in children treated in the Orthopedic and Traumatology Children Unit of our tertiary hospital over the period between 2007 and 2010. This study suggests that orthopedic treatment is a valid option for the treatment of this type of fractures, with radiological and functional results as good as those obtained with surgical treatment, avoiding surgical complications and decreasing the hospital stay.


Subject(s)
Elbow Injuries , Fracture Fixation, Internal/methods , Humeral Fractures/therapy , Orthopedic Procedures/methods , Casts, Surgical , Child , Child, Preschool , Cohort Studies , Female , Follow-Up Studies , Fracture Healing/physiology , Humans , Humeral Fractures/diagnostic imaging , Injury Severity Score , Intra-Articular Fractures/diagnostic imaging , Intra-Articular Fractures/therapy , Male , Radiography , Retrospective Studies , Risk Assessment , Time Factors , Treatment Outcome
13.
Eur J Pharmacol ; 701(1-3): 159-67, 2013 Feb 15.
Article in English | MEDLINE | ID: mdl-23340222

ABSTRACT

The relation between diabetes and stroke is bidirectional: diabetes is an important risk factor for ischemic stroke, and acute stroke frequently induces hyperglycemia. On the other hand, plasma B-type natriuretic peptide (BNP) levels are raised in diabetes and stroke. The purpose was to study how alloxan-induced diabetes might modify the effects of BNP in rabbit carotid arteries and the mechanisms involved in such actions. To do this, isometric tension in isolated rabbit carotid artery was recorded and prostanoids release and plasma NT-proBNP were measured by enzyme immunoassay. BNP induced a relaxation of phenylephrine-precontracted carotid arteries, and this relaxation was lower in diabetic than in control rabbits. Endothelium removal did not modify the relaxation to BNP in control rabbits but increased this relaxation in diabetic rabbits. In control rabbits, indomethacin inhibited the BNP-induced relaxation in the presence and in the absence of endothelium. In diabetic rabbits, indomethacin did not modify the BNP-induced relaxation in arteries with endothelium and inhibited it in arteries without endothelium. In the presence of BNP the carotid artery released thromboxane A2 and prostacyclin, and the release of endothelial prostacyclin was inhibited in diabetic rabbits. Glibenclamide and 4-aminopyridine inhibited the relaxation to BNP, and these inhibitions were lower in diabetic than in control rabbits. In conclusion, our results provide a new understanding concerning the mechanisms of the diabetes-induced hyporeactivity of the carotid artery to BNP, that at least include the loss of endothelial prostacyclin and a reduced participation of ATP-sensitive K(+) channels (KATP) and voltage-sensitive K(+) channels (KV).


Subject(s)
Carotid Arteries/drug effects , Diabetes Mellitus/metabolism , Epoprostenol/metabolism , Natriuretic Peptide, Brain/pharmacology , Potassium Channels/metabolism , Animals , Blood Glucose/metabolism , Body Weight/drug effects , Carotid Arteries/metabolism , Diabetes Mellitus/blood , Diabetes Mellitus/physiopathology , Dose-Response Relationship, Drug , Male , Natriuretic Peptide, Brain/blood , Nitric Oxide/metabolism , Peptide Fragments/blood , Potassium/metabolism , Rabbits , Receptors, Atrial Natriuretic Factor/metabolism
14.
Meat Sci ; 92(4): 816-22, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22878051

ABSTRACT

The meat sector in Spain is an important industry. However, traditional consumption is changing as a result of the country's economic crisis and the new structure of households. The objective of the present study was to identify trends in meat consumption in Spain extrapolated to 2016, and the main innovations that should be of interest to firms in the sector. The study was conducted in 2011 using the Delphi method with the participation of 26 experts. The results showed that, while the demand for meat will not vary significantly in amount, it will do so in composition, with chicken replacing beef as the meat of most importance in the shopping basket. In addition, significant growth is expected in certified meat, but the demand for organic meat will not take off. Neither will there be no significant changes in end purchase formats, but there will be a clear trend in consumers' purchasing decision criteria away from price, external appearance and origin towards quality certification and the attributes of the packaging. With respect to end purchase channels, the experts estimate that the current trend will be accentuated with increasing market share for large supermarkets and major distribution brands.


Subject(s)
Diet/trends , Diffusion of Innovation , Food Technology , Forecasting , Meat-Packing Industry/trends , Meat , Animals , Cattle , Chickens , Consumer Behavior/economics , Delphi Technique , Diet/economics , Diet/ethnology , Food Packaging/economics , Food Packaging/trends , Food Preferences/ethnology , Food Quality , Food Technology/economics , Food, Organic/economics , Humans , Marketing/economics , Marketing/trends , Meat/economics , Meat/standards , Meat-Packing Industry/economics , Meat-Packing Industry/methods , Social Change , Socioeconomic Factors , Spain
15.
Pharmacol Res ; 66(5): 392-400, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22898325

ABSTRACT

Diabetes is associated with increased prevalence of hypertension, cardiovascular and renal disease. Atrial natriuretic peptide (ANP) plays an important role in cardiovascular pathophysiology and is claimed to have cardioprotective and renoprotective effect in diabetic patients. The working hypothesis was that alloxan-induced diabetes might modify the vascular effects of ANP in isolated rabbit renal arteries and the mechanisms involved in such actions. Plasma ANP levels were higher in diabetic rabbits than in control rabbits. ANP (10(-12)-10(-7)M) induced a relaxation of precontracted renal arteries, which was lower in diabetic than in control rabbits. In arteries from both groups of animals, endothelium removal decreased the ANP-induced relaxation but inhibition of NO-synthesis did not modify ANP-induced relaxations. In KCl-depolarised arteries, relaxation to ANP was almost abolished both in control and diabetic rabbits. Tetraethylammonium (TEA) partly inhibited the relaxation to ANP in control rabbits but did not modify it in diabetic rabbits. Glibenclamide and 4-aminopyridine inhibited the relaxation to ANP, and these inhibitions were lower in diabetic than in control rabbits. Indomethacin potentiated the relaxation to ANP, more in control than in diabetic rabbits. In the presence of ANP the renal artery released thromboxane A(2) and prostacyclin, and the release of prostacyclin resulted decreased in diabetic rabbits. The present results suggest that diabetes produces hyporeactivity of the rabbit renal artery to ANP by mechanisms that at least include the reduced modulation by prostacyclin and a lower participation of ATP-sensitive K(+) channel (K(ATP)), voltage-sensitive K(+) channels (K(V)) and TEA-sensitive K(+) channels (K(Ca)).


Subject(s)
Atrial Natriuretic Factor/pharmacology , Diabetes Mellitus, Experimental/physiopathology , Epoprostenol/physiology , Renal Artery/drug effects , Vasodilation/drug effects , Animals , Atrial Natriuretic Factor/blood , Endothelium, Vascular/physiology , In Vitro Techniques , Male , Potassium Channels/physiology , Rabbits , Renal Artery/physiology , Tetraethylammonium/pharmacology , Thromboxane A2/physiology , Vasodilation/physiology
16.
Pharmacol Res ; 63(3): 190-8, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21073954

ABSTRACT

Atrial natriuretic peptide (ANP) plays an important role in the pathophysiology of the vascular complications in diabetes. The working hypothesis was that diabetes might modify the vascular actions of ANP in isolated rabbit carotid arteries and the mechanisms involved in these actions. ANP (10(-12)-10(-7)M) induced a relaxation of precontracted carotid arteries, which was lower in diabetic than in control rabbits. In arteries from both groups of animals, endothelium removal increased the ANP-induced relaxation. Isatin inhibited the relaxation to ANP both in arteries with and without endothelium. Carotid arteries from diabetic rabbits showed a decreased natriuretic peptide receptor (NPR)-A expression and an enhanced NPR-C expression. Inhibition of NO-synthesis did not modify ANP-induced relaxation in control rabbits but inhibited it in diabetic rabbits. In arteries with endothelium indomethacin enhanced the relaxation to ANP in control rabbits but did not modify it in diabetic rabbits. In endothelium-denuded arteries indomethacin inhibited the relaxation to ANP in both groups of animals. In KCl-depolarised arteries, relaxation to ANP was almost abolished both in control and diabetic rabbits. Tetraethylammonium inhibited the relaxation to ANP, and this inhibition was higher in diabetic than in control rabbits. These results suggest that diabetes produces hyporeactivity of the rabbit carotid artery to ANP by a mechanism that at least includes a reduced expression of NPR-A, an enhanced expression of NPR-C and a reduced participation of K(+)-channels. Furthermore, diabetes enhances endothelial NO release and diminishes the ratio thromboxane A(2)/prostacyclin. This increase of vasodilators could result from compensatory mechanisms counteracting the arterial hyporeactivity to ANP.


Subject(s)
Atrial Natriuretic Factor/physiology , Carotid Arteries/metabolism , Diabetes Mellitus, Experimental/metabolism , Down-Regulation/physiology , Vasodilation/physiology , Animals , Diabetes Mellitus, Experimental/physiopathology , Male , Rabbits , Random Allocation
17.
Langmuir ; 26(24): 19106-13, 2010 Dec 21.
Article in English | MEDLINE | ID: mdl-21090824

ABSTRACT

Despite the fair number of microencapsulation principles that have been developed, the actual protection and targeted delivery of sensitive ingredients remains a challenge in the food industry. A suitable technique should use food-grade and inexpensive materials, and ensure tight control over the capsule size and release trigger mechanism. For example, encapsulates may need to survive the low pH of the stomach to release their contents in the neutral environment of the small intestine. In this work we present layer-by-layer (LbL) microcapsules assembled from whey protein isolate (WPI), high-methoxyl pectin (HMP) and WPI-fibrils. The narrow size distribution of these capsules is determined by the oil-in-water droplets used as templates, and their mechanical properties and pH response can be tuned by the number of layers adsorbed. Capsules with more than eight layers have a mechanical strength comparable to chemically cross-linked polymer capsules, because of the reinforcement by the WPI-fibrils in combination with the shell completion. Typically, capsules with five layers survive pH 2 for more than 2 h, but dissolve within 30 min at pH 7. At higher number of layers, the capsules are even more stable. Contrary to other encapsulates, these capsules can be dried and are suitable for application in dry products.


Subject(s)
Mechanical Phenomena , Microtechnology/methods , Milk Proteins/chemistry , Adsorption , Capsules , Hydrogen-Ion Concentration , Microscopy , Oils/chemistry , Pectins/chemistry , Static Electricity , Surface Properties , Whey Proteins
18.
Neurochem Int ; 56(8): 991-8, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20420875

ABSTRACT

Parkinson's disease and other neurodegenerative disorders associated to changes in alpha-synuclein often result in autonomic dysfunction, most of the time accompanied by abundant expression of this synaptic protein in peripheral autonomic neurons. Given that expression of alpha-synuclein in vascular elements has been previously reported, the present study was undertaken to determine whether alpha-synuclein directly participates in the regulation of vascular responsiveness. We detected by immunohistochemistry perivascular nerve fibers containing alpha-synuclein in the aorta of mice while aortic endothelial cells and muscular fibers themselves did not exhibit detectable levels of this protein. To assess the effect of alpha-synuclein on vascular reactivity, aortic ring preparations obtained from alpha-synuclein-deficient knockout mice and from transgenic mice overexpressing human wild-type alpha-synuclein under the control of the tyrosine hydroxylase-promoter were mounted and equilibrated in organ baths for isometric tension recording. Lack of alpha-synuclein did not modify the relaxant responses to the endothelium-dependent (acetylcholine) and -independent (sodium nitroprusside) vasodilators, but resulted in a greater than normal norepinephrine-induced vasoconstriction along with a lowered response to dopamine, suggesting potential presynaptic changes in dopamine and norepinephrine releases in knockout mice. Overexpression of alpha-synuclein in TH-positive fibers resulted in complex abnormal responses, characterized by lowered acetylcholine-induced relaxation and lowered norepinephrin-induced contraction. Taken together, our data show for the first time that alpha-synuclein is present in sympathetic fibers supplying the murine aorta and provide evidence that changes in alpha-synuclein levels in perivascular fibers play a physiological role in the regulation of vascular function.


Subject(s)
Aorta, Thoracic/innervation , Autonomic Nervous System Diseases/metabolism , Muscle, Smooth, Vascular/innervation , Parkinson Disease/metabolism , Sympathetic Fibers, Postganglionic/metabolism , alpha-Synuclein/metabolism , Animals , Aorta, Thoracic/physiology , Autonomic Nervous System Diseases/physiopathology , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Muscle Contraction/drug effects , Muscle Contraction/genetics , Muscle, Smooth, Vascular/physiology , Parkinson Disease/physiopathology , Presynaptic Terminals/drug effects , Presynaptic Terminals/metabolism , Sympathetic Fibers, Postganglionic/drug effects , Sympathetic Fibers, Postganglionic/physiopathology , Vasoconstriction/drug effects , Vasoconstriction/genetics , alpha-Synuclein/deficiency , alpha-Synuclein/genetics
19.
Pharmacol Res ; 61(2): 149-56, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19755160

ABSTRACT

Kidney disease is a frequent complication in diabetes, and significant differences have been reported between male and female patients. Our working hypothesis was that diabetes might modify the vascular actions of testosterone in isolated rabbit renal arteries and the mechanisms involved in these actions. Testosterone (10(-8) to 10(-4)M) induced relaxation of precontracted arteries, without significant differences between control and diabetic rabbits. Both in control and diabetic rabbits endothelium removal inhibited testosterone relaxant action. In arteries with endothelium, incubation with indomethacin (10(-5)M), N(G)-nitro-l-arginine (10(-5)M) or tetraethylammonium (10(-5)M) did not modify relaxations to testosterone neither in control nor in diabetic rabbits. In endothelium-denuded arteries indomethacin enhanced the relaxant action of testosterone, both in control and diabetic rabbits. In arteries from diabetic rabbits, eNOS, iNOS and COX-1 expression and testosterone-induced release of thromboxane A(2) and prostacyclin were not significantly different from those observed in control rabbits. However, COX-2 expression was significantly lower in diabetic rabbits that in control rabbits. In nominally Ca(2+)-free medium, cumulative addition of CaCl2 (10(-5) to 3x10(-2)M) contracted previously depolarized arteries. Testosterone (10(-4)M) inhibited CaCl2 contractions of the renal artery both in control and diabetic rabbits. These results show that testosterone relaxes the renal artery both in control and diabetic rabbits. This relaxation is modulated by muscular thromboxane A(2), it is partially mediated by endothelial prostacyclin, and it involves the blocking of extracellular Ca2+ entry. Diabetes does not modify the mechanisms involved in the relaxant action of testosterone in the rabbit renal artery.


Subject(s)
Diabetes Mellitus, Experimental/metabolism , Renal Artery/metabolism , Testosterone/metabolism , Vasodilation , Animals , Blood Glucose/metabolism , Blotting, Western , Calcium/metabolism , Cyclooxygenase 1/metabolism , Cyclooxygenase 2/metabolism , Cyclooxygenase Inhibitors/pharmacology , Diabetes Mellitus, Experimental/physiopathology , Dose-Response Relationship, Drug , Endothelium, Vascular/metabolism , Endothelium, Vascular/physiopathology , Immunoenzyme Techniques , Indomethacin/pharmacology , Male , Muscle, Smooth, Vascular/metabolism , Muscle, Smooth, Vascular/physiopathology , Nitric Oxide Synthase Type II/antagonists & inhibitors , Nitric Oxide Synthase Type II/metabolism , Nitric Oxide Synthase Type III/antagonists & inhibitors , Nitric Oxide Synthase Type III/metabolism , Nitroarginine/pharmacology , Potassium/metabolism , Potassium Channel Blockers/pharmacology , Prostaglandins I/metabolism , Rabbits , Renal Artery/physiopathology , Signal Transduction , Testosterone/blood , Tetraethylammonium/pharmacology , Thromboxane A2/metabolism
20.
Pharmacol Res ; 61(1): 62-70, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19573602

ABSTRACT

Cardiovascular disease is the major cause of morbidity and mortality in diabetic patients, which in turn is also associated with low levels of serum testosterone. The working hypothesis was that diabetes might modify the mechanisms involved in the vascular actions of testosterone in isolated rabbit carotid arteries. Testosterone (10(-8)-3x10(-4)M) induced a concentration-dependent relaxation of precontracted carotid arteries, which was higher in diabetic than in control rabbits. In control rabbits neither endothelium removal nor the nitric oxide synthase (NOS) inhibitor N(G)-nitro-l-arginine (l-NOArg, 10(-5)M) modified the relaxant action of testosterone, and the cyclooxygenase (COX) inhibitor indomethacin (10(-5)M) enhanced this relaxation. In contrast, in diabetic rabbits endothelium removal, l-NOArg (10(-5)M) or indomethacin (10(-5)M) inhibited the testosterone induced relaxation. In arteries from diabetic rabbits, eNOS, iNOS and COX-2 expression and testosterone induced release of prostacyclin resulted enhanced in comparison with arteries from control rabbits. Testosterone (10(-4)M) strongly inhibited CaCl(2) (10(-5)-3x10(-2)M) concentration-related contractions of the carotid artery both in control and diabetic rabbits. These results suggest that testosterone relaxes the rabbit carotid artery by blocking the extracellular calcium entry. Diabetes enhances the vasodilator response of the rabbit carotid artery to testosterone by a mechanism that at least includes an increased modulatory activity of the endothelial nitric oxide and an augmented release of COX-2 vasodilator, prostacyclin rather than the absence of COX-1 vasoconstrictor, thromboxane A(2). The hypotestosteronemia observed in diabetic rabbits could be a consequence of the increased expression of iNOS and could contribute to the hyperreactivity of the rabbit carotid artery to testosterone.


Subject(s)
Carotid Arteries/enzymology , Carotid Artery Diseases/etiology , Cyclooxygenase 2/metabolism , Diabetes Mellitus, Experimental/enzymology , Diabetic Angiopathies/etiology , Nitric Oxide Synthase Type III/metabolism , Nitric Oxide Synthase Type II/metabolism , Testosterone/metabolism , Vasodilation , Animals , Apamin/pharmacology , Blood Glucose/metabolism , Blotting, Western , Calcium/metabolism , Carotid Arteries/drug effects , Carotid Arteries/physiopathology , Carotid Artery Diseases/enzymology , Carotid Artery Diseases/physiopathology , Charybdotoxin/pharmacology , Cyclooxygenase Inhibitors/pharmacology , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/physiopathology , Diabetic Angiopathies/enzymology , Diabetic Angiopathies/physiopathology , Dose-Response Relationship, Drug , Endothelium, Vascular/enzymology , Endothelium, Vascular/physiopathology , Epoprostenol/metabolism , Immunoenzyme Techniques , Indomethacin/pharmacology , Male , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/antagonists & inhibitors , Nitric Oxide Synthase Type III/antagonists & inhibitors , Nitroarginine/pharmacology , Potassium/metabolism , Potassium Channel Blockers/pharmacology , Rabbits , Thromboxane A2/metabolism , Vasodilation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...